Skip to main content
. 2022 Sep 7;13:970553. doi: 10.3389/fphar.2022.970553

FIGURE 1.

FIGURE 1

Performance of NAMPT inhibitors in various cancer cell lines (Tateishi et al., 2015; Peterse et al., 2017).